首页> 外国专利> HEPATITIS B VIRUS INFECTION THERAPEUTIC AGENT, AND PHARMACEUTICAL COMPOSITION FOR HEPATITIS B VIRUS INFECTION

HEPATITIS B VIRUS INFECTION THERAPEUTIC AGENT, AND PHARMACEUTICAL COMPOSITION FOR HEPATITIS B VIRUS INFECTION

机译:乙型肝炎病毒感染治疗剂和乙型肝炎病毒感染的药物成分

摘要

PROBLEM TO BE SOLVED: To provide a therapeutic agent that has high hydrophobicity and shows effective anti-hepatitis B virus action through the action to inhibit sugar chain formation in viral membrane.;SOLUTION: The hepatitis B virus infection therapeutic agent comprises a compound represented by general formula (1), or its pharmaceutically acceptable salt as an active ingredient, where R1, R2, R3 and R4 are a hydrogen atom or a C1-C10 alkyl group; R5 is a hydrogen atom, a hydroxy group or a C1-C10 alkyl group; Z is a group represented by general formula (2), general formula (3) or general formula (4).;SELECTED DRAWING: None;COPYRIGHT: (C)2017,JPO&INPIT
机译:解决的问题:提供一种具有高疏水性并通过抑制病毒膜中糖链形成的作用而显示出有效的抗乙型肝炎病毒作用的治疗剂。通式(1)或其药学上可接受的盐为有效成分,其中R 1 ,R 2 ,R 3 和R 4 为氢原子或C1-C10烷基; R 5 是氢原子,羟基或碳数1〜10的烷基。 Z是由通式(2),通式(3)或通式(4)表示的基团。;选择制图:无;版权:(C)2017,日本特许进阶

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号